Creating Capital Market Tools
for the Healthcare Economy

Enabling Capital Markets in Healthcare.


Poliwogg applies metrics specific to biotechnology and pharmaceuticals that are not applicable to other sectors or industries, resulting in highly idiosyncratic performance characteristics. Indexes are comprised of companies that are principally engaged in the US health care sector, with a strong emphasis on the dynamic small/mid-capitalization biotechnology segment.

Learn More

We Believe

  • Current investment products in healthcare reflect neither the opportunity nor the complexity of healthcare
  • The capital markets should support healthcare with financial products as completely as other sectors
  • Healthcare should be a financial asset, not just a cost
  • Technology enables discovery, transparency and exciting new products
  • The pace of scientific innovation is accelerating

Poliwogg In the News